Cargando…
COVID‐19, thromboembolic risk, and Virchow's triad: Lesson from the past
COronavirus Infectious Disease which started in 2019 (COVID‐19) usually presents with the signs and symptoms of pneumonia. However, a growing number of recent reports highlight the fact that the infection may be by far more than only a respiratory disease. There is evidence of an increased thromboem...
Autores principales: | Mehta, Jawahar L., Calcaterra, Giuseppe, Bassareo, Pier P. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wiley Periodicals, Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7724210/ https://www.ncbi.nlm.nih.gov/pubmed/33176009 http://dx.doi.org/10.1002/clc.23460 |
Ejemplares similares
-
Letter in response to “COVID‐19, Virchow's triad and thromboembolic risk in obese pregnant women”
por: Calcaterra, Giuseppe, et al.
Publicado: (2021) -
COVID‐19, Virchow's triad and thromboembolic risk in obese pregnant women
por: Carbillon, Lionel, et al.
Publicado: (2021) -
COVID-19 Presenting as Major Thromboembolic Events: Virchow’s Triad Revisited and Clinical Considerations of Therapeutic Anticoagulation
por: Zheng, Haoyi, et al.
Publicado: (2020) -
Virchow’s Triad and the Role of Thrombosis in COVID-Related Stroke
por: Gonzalez-Gonzalez, Francisco J., et al.
Publicado: (2021) -
The Effect of Anticoagulation Use on Mortality in COVID-19 Infection
por: Salah, Husam M., et al.
Publicado: (2020)